BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ovesjö ML, Skilving I, Bergman P, Rane A, Ekström L, Björkhem-Bergman L. Low Vitamin D Levels and Genetic Polymorphism in the Vitamin D Receptor are Associated with Increased Risk of Statin-Induced Myopathy. Basic Clin Pharmacol Toxicol 2016;118:214-8. [PMID: 26423691 DOI: 10.1111/bcpt.12482] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Muñoz-Blanco A, Gómez-Huelgas R, Gómez-Cerezo JF. Statin-associated muscle symptoms: Myth or reality? Rev Clin Esp (Barc) 2022:S2254-8874(22)00051-0. [PMID: 35810133 DOI: 10.1016/j.rceng.2022.03.006] [Reference Citation Analysis]
2 Muñoz-blanco A, Gómez-huelgas R, Gómez-cerezo J. Sintomatología muscular asociada a estatinas: ¿mito o realidad? Revista Clínica Española 2022. [DOI: 10.1016/j.rce.2022.03.013] [Reference Citation Analysis]
3 Hou Q, Pang C, Chen Y. Association Between Vitamin D and Statin-Related Myopathy: A Meta-analysis. Am J Cardiovasc Drugs 2022;22:183-93. [PMID: 34296397 DOI: 10.1007/s40256-021-00492-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
4 Kassner U, Grunwald S, Spira D, Buchmann N, Bobbert T, Gazzerro E, Hollstein T, Spuler S, Steinhagen-Thiessen E. [Diagnostics and treatment of statin-associated muscle symptoms]. Internist (Berl) 2021;62:827-40. [PMID: 34143250 DOI: 10.1007/s00108-021-01059-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Xiang Q, Zhang XD, Mu GY, Wang Z, Liu ZY, Xie QF, Hu K, Zhang Z, Ma LY, Jiang J, Cui YM. Correlation between single-nucleotide polymorphisms and statin-induced myopathy: a mixed-effects model meta-analysis. Eur J Clin Pharmacol 2021;77:569-81. [PMID: 33150478 DOI: 10.1007/s00228-020-03029-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kee PS, Chin PKL, Kennedy MA, Maggo SDS. Pharmacogenetics of Statin-Induced Myotoxicity. Front Genet 2020;11:575678. [PMID: 33193687 DOI: 10.3389/fgene.2020.575678] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
7 Duan BL, Mao YR, Xue LQ, Yu QY, Liu MY. Determination of vitamin D and analysis of risk factors for osteoporosis in patients with chronic pain. World J Clin Cases 2020; 8(11): 2150-2161 [PMID: 32548145 DOI: 10.12998/wjcc.v8.i11.2150] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Azemawah V, Movahed MR, Centuori P, Penaflor R, Riel PL, Situ S, Shadmehr M, Hashemzadeh M. State of the Art Comprehensive Review of Individual Statins, Their Differences, Pharmacology, and Clinical Implications. Cardiovasc Drugs Ther 2019;33:625-39. [PMID: 31773344 DOI: 10.1007/s10557-019-06904-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
9 Nikolic D, Banach M, Chianetta R, Luzzu LM, Pantea Stoian A, Diaconu CC, Citarrella R, Montalto G, Rizzo M. An overview of statin-induced myopathy and perspectives for the future. Expert Opin Drug Saf 2020;19:601-15. [PMID: 32233708 DOI: 10.1080/14740338.2020.1747431] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
10 Chogtu B, Ommurugan B, Thomson SR, Kalthur SG. Effect of Vitamin D Analogue on Rosuvastatin-Induced Myopathy in Wistar Rats. ScientificWorldJournal 2020;2020:4704825. [PMID: 32292293 DOI: 10.1155/2020/4704825] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Bellosta S, Corsini A, Ferri N. Risk Factors for SAMS. In: Thompson PD, Taylor BA, editors. Statin-Associated Muscle Symptoms. Cham: Springer International Publishing; 2020. pp. 51-61. [DOI: 10.1007/978-3-030-33304-1_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Peng J, Liu Y, Xie J, Yang G, Huang Z. Effects of vitamin D on drugs: Response and disposal. Nutrition 2020;74:110734. [PMID: 32179384 DOI: 10.1016/j.nut.2020.110734] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
13 Brunham LR, Baker S, Mammen A, Mancini GBJ, Rosenson RS. Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence. Cardiovasc Res 2018;114:1073-81. [PMID: 29878063 DOI: 10.1093/cvr/cvy119] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 13.0] [Reference Citation Analysis]
14 Saini A, Björkhem-Bergman L, Boström J, Lilja M, Melin M, Olsson K, Ekström L, Bergman P, Altun M, Rullman E, Gustafsson T. Impact of vitamin D and vitamin D receptor TaqI polymorphism in primary human myoblasts. Endocr Connect 2019;8:1070-81. [PMID: 31252402 DOI: 10.1530/EC-19-0194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Taylor BA, Thompson PD. Statin-Associated Muscle Disease: Advances in Diagnosis and Management. Neurotherapeutics 2018;15:1006-17. [PMID: 30251222 DOI: 10.1007/s13311-018-0670-z] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]
16 Bergström H, Brånvall E, Helde-Frankling M, Björkhem-Bergman L. Differences in discontinuation of statin treatment in women and men with advanced cancer disease. Biol Sex Differ 2018;9:47. [PMID: 30342545 DOI: 10.1186/s13293-018-0207-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Wu Z, Malihi Z, Stewart AW, Lawes CM, Scragg R. The association between vitamin D concentration and pain: a systematic review and meta-analysis. Public Health Nutr 2018;21:2022-37. [DOI: 10.1017/s1368980018000551] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 9.0] [Reference Citation Analysis]
18 Shahabi P, Lamothe F, Dumas S, Rouleau-Mailloux É, Feroz Zada Y, Provost S, Asselin G, Mongrain I, Valois D, Gaulin Marion MJ, Lemieux Perreault LP, Perreault S, Dubé MP. Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort. Pharmacogenomics J 2019;19:147-56. [PMID: 29298995 DOI: 10.1038/s41397-017-0005-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
19 Helde-Frankling M, Björkhem-Bergman L. Vitamin D in Pain Management. Int J Mol Sci 2017;18:E2170. [PMID: 29057787 DOI: 10.3390/ijms18102170] [Cited by in Crossref: 61] [Cited by in F6Publishing: 69] [Article Influence: 12.2] [Reference Citation Analysis]
20 Helde-Frankling M, Höijer J, Bergqvist J, Björkhem-Bergman L. Vitamin D supplementation to palliative cancer patients shows positive effects on pain and infections-Results from a matched case-control study. PLoS One 2017;12:e0184208. [PMID: 28859173 DOI: 10.1371/journal.pone.0184208] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
21 Buttar RS, Batra J, Kreimerman J, Aleta M, Melamed ML. Rhabdomyolysis and AKI with Atorvastatin and Sitagliptin Use in the Setting of Low 25-Hydroxyvitamin D Levels. J Gen Intern Med 2017;32:1156-9. [PMID: 28707259 DOI: 10.1007/s11606-017-4115-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
22 du Souich P, Roederer G, Dufour R. Myotoxicity of statins: Mechanism of action. Pharmacology & Therapeutics 2017;175:1-16. [DOI: 10.1016/j.pharmthera.2017.02.029] [Cited by in Crossref: 87] [Cited by in F6Publishing: 72] [Article Influence: 17.4] [Reference Citation Analysis]
23 Taylor BA, Lorson L, White CM, Thompson PD. Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain. Atherosclerosis 2017;256:100-4. [PMID: 27993387 DOI: 10.1016/j.atherosclerosis.2016.11.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
24 Neřoldová M, Stránecký V, Hodaňová K, Hartmannová H, Piherová L, Přistoupilová A, Mrázová L, Vrablík M, Adámková V, Hubáček JA, Jirsa M, Kmoch S. Rare variants in known and novel candidate genes predisposing to statin-associated myopathy. Pharmacogenomics 2016;17:1405-14. [PMID: 27296017 DOI: 10.2217/pgs-2016-0071] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
25 Björkhem-Bergman L, Bergman P. Vitamin D and patients with palliative cancer. BMJ Support Palliat Care 2016;6:287-91. [PMID: 27084421 DOI: 10.1136/bmjspcare-2015-000921] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
26 Banach M, Aronow WS, Serban MC, Rysz J, Voroneanu L, Covic A. Lipids, blood pressure and kidney update 2015. Lipids Health Dis 2015;14:167. [PMID: 26718096 DOI: 10.1186/s12944-015-0169-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 47] [Article Influence: 5.3] [Reference Citation Analysis]